Dusquetide modulates innate immune response through binding to p62

Highlights

• Next-generation IDR dusquetide penetrates the cell membrane

• Dusquetide targets the ZZ domain of p62

• Dusquetide binding modulates the p62-RIP1 complex

• Dusquetide binding increases p38 phosphorylation and enhances CEBP/B expression

Summary

SQSTM1/p62 is an autophagic receptor that plays a major role in mediating stress and innate immune responses. Preclinical studies identified p62 as a target of the prototype innate defense regulator (IDR); however, the molecular mechanism of this process remains unclear. Here, we describe the structural basis and biological consequences of the interaction of p62 with the next generation of IDRs, dusquetide. Both electrostatic and hydrophobic contacts drive the formation of the complex between dusquetide and the ZZ domain of p62. We show that dusquetide penetrates the cell membrane and associates with p62 in vivo. Dusquetide binding modulates the p62-RIP1 complex, increases p38 phosphorylation, and enhances CEBP/B expression without activating autophagy. Our findings provide molecular details underlying the IDR action that may help in the development of new strategies to pharmacologically target p62.